![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2006 by The American Society of Human Genetics. All rights reserved. A Three–Single-Nucleotide Polymorphism Haplotype in Intron 1 of OCA2 Explains Most Human Eye-Color Variation From the Queensland Institute of Medical Research (D.L.D.; G.W.M.; Z.Z.Z.; L.L.; M.R.J.; N.K.H.; N.G.M.) and Institute for Molecular Bioscience, University of Queensland (W.C.; R.A.S.), Brisbane, Australia Address for correspondence and reprints: Dr. Richard A. Sturm, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. E-mail: R.Sturm/at/imb.uq.edu.au *These authors contributed equally to this work. Received September 5, 2006; Accepted November 15, 2006. This article has been cited by other articles in PMC.Abstract We have previously shown that a quantitative-trait locus linked to the OCA2 region of 15q accounts for 74% of variation in human eye color. We conducted additional genotyping to clarify the role of the OCA2 locus in the inheritance of eye color and other pigmentary traits associated with skin-cancer risk in white populations. Fifty-eight synonymous and nonsynonymous exonic single-nucleotide polymorphisms (SNPs) and tagging SNPs were typed in a collection of 3,839 adolescent twins, their siblings, and their parents. The highest association for blue/nonblue eye color was found with three OCA2 SNPs: rs7495174 T/C, rs6497268 G/T, and rs11855019 T/C (P values of 1.02×10-61, 1.57×10-96, and 4.45×10-54, respectively) in intron 1. These three SNPs are in one major haplotype block, with TGT representing 78.4% of alleles. The TGT/TGT diplotype found in 62.2% of samples was the major genotype seen to modify eye color, with a frequency of 0.905 in blue or green compared with only 0.095 in brown eye color. This genotype was also at highest frequency in subjects with light brown hair and was more frequent in fair and medium skin types, consistent with the TGT haplotype acting as a recessive modifier of lighter pigmentary phenotypes. Homozygotes for rs11855019 C/C were predominantly without freckles and had lower mole counts. The minor population impact of the nonsynonymous coding-region polymorphisms Arg305Trp and Arg419Gln associated with nonblue eyes and the tight linkage of the major TGT haplotype within the intron 1 of OCA2 with blue eye color and lighter hair and skin tones suggest that differences within the 5′ proximal regulatory control region of the OCA2 gene alter expression or messenger RNA–transcript levels and may be responsible for these associations. The pigmentary traits of skin, hair, and eye color combined with high levels of environmental UV exposure are potential modulators of individual risk for developing both melanoma and nonmelanoma skin cancer (NMSC).1 The incidence rate of both NMSC and melanoma is greatest in fair-skinned, sun-sensitive individuals, which indicates the importance of the innate ability to respond to UV light through an increased synthesis of melanin, known as the “tanning response.” The quantity and quality of melanin pigmentation is central to the photoprotection of both melanocytes and keratinocytes. The human melanocortin-1 receptor (MC1R [MIM 155555]) protein, expressed on the surface of melanocytes, is a key determinant of photosensitivity,2,3 with variant alleles of this seven-transmembrane G-protein–coupled receptor, present at high frequency in white populations, linked to the high incidences of NMSC and melanoma.4 Other genes involved in melanin biogenesis modify the penetrance of MC1R variant alleles. The gene responsible for oculocutaneous albinism type II (OCA2), which encodes the P protein, is an integral melanosomal membrane protein with an 838-aa ORF that contains 12 transmembrane-spanning regions.5 OCA2 maps6 to chromosome 15q11.2-q12 and is the human homologue of the mouse pink-eyed dilution gene (p) (Entrez Nucleotide accession number NM_000275).7,8 Epistatic interactions between MC1R and the OCA2 gene were first reported to contribute to skin pigmentation phenotypes in a Tibetan population.9 OCA2 transcription is induced following UV-B irradiation of skin,10 and, together with MC1R, plays important roles in control of pigmentation.11 Polymorphisms in OCA2 occur in different populations,12 and this locus underlies the genetic linkage of blue/brown eye (BEY2/EYCL3 [MIM 227220]) and brown hair (HCL3 [MIM 601800]) to chromosome 15, as reported elsewhere.13 Two OCA2 coding-region variant alleles—Arg305Trp and Arg419Gln—were recently shown to be associated with brown and green/hazel eye colors, respectively,14,15 and blue eye color has also been linked to this locus through use of microsatellite16,17 and SNP18 markers. Indeed, our genomewide linkage scan for eye color suggested that 74% of variation in eye color in Europeans could be attributed to a QTL linked to the OCA2 region of chromosome 15q.16 To understand how alleles of the OCA2 gene influence eye color and pigmentation associated with skin-cancer risk, we sequenced all OCA2 exons encoding the P protein. To test for statistical association with pigmentary traits, we typed the exonic polymorphisms detected in our preliminary study combined with those reported in the literature and haplotype-tagging SNPs identified from the HapMap database19 (International HapMap Project) in a large twin family sample of adolescents phenotyped for melanoma risk factors, including eye, skin, and hair color; mole (melanocytic nevus) count; and degree of freckling (ephelidae). Material and Methods Structure of the Study Population and Pigmentation Characteristics Adolescent twins and their siblings were recruited for an investigation of genetic and environmental factors contributing to the development of pigmented nevi20,21 and were also phenotyped for pigment traits, including skin, hair, and eye color. The pigmentation characteristics of the twins were examined on up to three occasions, at ages 12, 14, and 16 years, as described elsewhere.22 Subjects were overwhelmingly (>95%) of northern European origin (mainly Anglo-Celtic). One research nurse (A. Eldridge) rated hair color on a five-category scale (1=fair/blond, 2=light brown, 3=red/auburn, 4=dark brown, 5=black), eye color (1=blue/gray, 2=green/hazel, 3=brown), and skin color at the inner upper left arm (1=fair/pale, 2=medium, 3=olive/dark). Density of ephelidae was recorded at three body sites (face, dorsum of right hand, and shoulders) on a four-point scale (0=none, 1=mild/infrequent/sparse, 2=moderate/evenly distributed, 3=severe). For most analyses, a composite freckling score was constructed by summing the scores for the three sites. Parents were not clinically examined, so their skin, hair (as at age 21), and eye colors were obtained by self-report. Melanocytic nevi were counted on all subjects by a single observer (A. Eldridge) on all parts of the body except chest, abdomen, buttocks, and scalp. Counts were recorded separately for 34 regions, by diameter (0–2 mm, 2–5 mm, or >5 mm) and were further classified as flat, raised, or atypical (see the work of Zhu et al.21 for more detail). There were 5,075 family members in 1,100 pedigrees with some phenotypic data, and DNA was available for genotyping for 3,839 individuals within 1,037 of these pedigrees. Phenotypic data for the genotyped subset are collated in table 1. With the exclusion of one member of each genotyped MZ twin pair, there were 3,011 individuals with complete record of OCA2 genotype, hair color, eye color, and sex. We analyzed the data collected when the twins were aged 12 years, since our data for this age group were most complete.
OCA2 Exon Amplification, Transgenomic Wave Mutation–Detection System, and DNA Sequencing To search for human OCA2 polymorphisms present in the southeast Queensland twin collection, we analyzed genomic DNA samples from 40 individuals: 9 with red/auburn hair, 10 each with fair/blond and light brown hair, and 11 with dark brown hair (representing 23 blue/gray, 9 green/hazel, and 8 brown eye colors). PCRs were conducted for each OCA2 coding-region exon (amplimers and size products for each OCA2 coding-region exon are available on request) that encompassed the six reported amino acids changing alleles Ala257Asp, Arg305Trp, Arg419Gln, Leu440Phe, His615Arg, and Ile722Thr.6,12,14,23,24 PCR products were denatured and analyzed on a Transgenomic Wave System (model 2100D), for mutation detection, by use of the Navigator Software package. Samples with a mismatch in the analyzed PCR fragment were sequenced from new PCR products through use of ABI BigDye Terminator version 3.1 chemistry and were separated on a capillary-based genetic analyzer (Applied Biosystems). Sequence chromatograms were analyzed using the Sequencher program (Gene Codes). OCA2 SNP Genotyping A combination of exonic and intronic SNPs (table 2) and 40 SNPs selected from the HapMap database19 (International HapMap Project) as suitable for haplotype coverage of the OCA2 locus were used to test for association with a range of pigmentary traits (table 3). Assays were designed for 75 SNPs through use of the Sequenom MassARRAY Assay Design software (version 3.0) (data available on request). Four SNPs (rs3751651, rs728405, rs7171246, and rs7496968) failed during the design and testing stage and were excluded. SNPs were typed using iPLEX chemistry on a Compact MALDI-TOF Mass Spectrometer (Sequenom) through use of standard methods.25
Statistical Methods We performed standard linear and logistic regression analyses of the data, using the R computer package (version 2.3.1 [R Development Core Team 2006]), as well as recursive partitioning tree-based analyses, using the R party package.26 We used MENDEL27 to perform individual SNP and haplotypic association analysis, which correctly allows for the relatedness within the sample. Plots of inter-SNP linkage disequilibrium were prepared using the Haploview program.28 Results Pigmentation Characteristics The frequencies of eye, hair, and skin color ratings (table 1) are consistent with those reported elsewhere for the southeast Queensland population,16,22,29 although a somewhat higher percentage of dark brown hair (43.3% vs. 34%) and medium skin (47.6% vs. 40.8%) colors, with a corresponding decrease in other hair-color classifications, were observed in the present combined study. The eye-color grade distributions were similar to our earlier reports, with 46.1% blue/gray, 27.7% green/hazel, 26.3% brown in the total sample collection. The genotyped subjects were ~52% female and ~48% male, and there were no significant differences in eye-color distributions between females and males. There was a very wide range in the number of freckles (nil to severe) and of nevi (2–426); 76% of the sample had some freckling on at least one of the three examined body sites. On average, males had nine more moles than did females, and a similar trend was observed for freckling, which was particularly obvious on the shoulders. This male excess has been noted elsewhere; red-haired subjects of both sexes showed the greatest number of freckles and the least number of moles, consistent with a number of other past22 and recent30 reports. Search for Polymorphism in OCA2 Exonic Regions in Adolescent Twins Selected for a Range of Hair and Eye Colors The human P-gene transcript encoded by the OCA2 locus is divided into 24 exons (fig. 1C
DNA analysis of 40 individuals in our study identified 10 coding-region SNPs and 10 flanking intronic-region SNPs (table 2) that confirmed the presence and allele frequencies of several of the polymorphisms that had already been described in the literature 12 for the white population. During this screening, two novel nonsynonymous changes—Val380Met (National Center for Biotechnology Information [NCBI] number ss66538500) and Val519Ala (NCBI ss66538502)—were discovered that were present at low frequencies—0.01 and 0.04, respectively—in the test subcollection of 80 alleles. Notably, the Val443Ile change reported as an albinism allele31 was also found at the low frequency of 0.02; although it resulted in a deficient P-protein activity, this may represent a hypomorphic allele in the general population rather than a private mutation, as it has also been reported by others.15 The Ala481Thr albinism-related polymorphism,31 present at high levels within the Japanese population,32 was seen neither in this discovery search nor during the screening of the complete collection. Whereas no new synonymous changes were seen in the exonic regions of the PCR products, two changes that have not been reported elsewhere were seen within intronic flanks IVS5-53 (NCBI ss66538498) C/G and IVS18+45 (NCBI ss66538504) G/C at frequencies of 0.02 and 0.04, respectively. Assay of OCA2 SNP Alleles and Haplotype Determination in an Adolescent Twin Collection No new common nonsynonymous variants in the OCA2 gene were detected in the 23 coding-region exons assayed in the test subcollection. We typed all of the 30 reported synonymous and nonsynonymous coding-region polymorphisms and five flanking intronic SNPs showing high polymorphism, including the new IVS5-53 C/G change (table 2), together with 40 HapMap tagging SNPs (table 3). Of the 75 selected SNPs, four failed during the design and testing stage; of the remaining 71 SNPs, a further 13 were dropped from the analysis, either because of low minor-allele frequency or because of Hardy-Weinberg disequilibrium, suggestive of additional assay problems. A total of 3,839 subjects were genotyped, with the final 58 SNPs used for statistical analyses (table 3). For coding-region SNPs, the synonymous changes Ala355Ala, Cys517Cys, Ala776Ala, and Ser788Ser were present at high frequency. The Gly780Gly variant was monomorphic for the T allele in our twin sample collection, in contrast to the report of Lee et al.,12 who found the T allele at a frequency of 0.27 in whites. Only the nonsynonymous changes Arg305Trp at 0.05 and Arg419Gln at 0.09 polymorphisms could be considered to be common in the southeast Queensland white population. The alanine amino acid allele was found exclusively at position 257, consistent with the report of Lee et al.12 but in contrast to the RefSeq entry for the cDNA for this gene. Figure 1A Association of OCA2 SNP Alleles with Blue Eye Color A plot of the maximum likelihood-ratio test statistic (LRTS) for association with blue/nonblue eye color is shown in fig. 1B In a separate analysis combining all tested SNPs, a recursive partitioning approach was applied to predict eye color on the basis of the 58 informative SNPs.26 A subset of 18 SNPs—beginning with the highest associated SNP rs6497268, then rs7495174 and rs11855019—were selected by this algorithm as significant predictors of blue or brown eye color. Use of these SNPs correctly predicted blue or brown eye color with a specificity of up to 80% in several nodes, with >50% of a major node of 1,113 samples having blue eyes (fig. 2
Association of OCA2 SNP Haplotypes with Eye, Hair, and Skin Color Given the facts that the three OCA2 intron 1 SNPs were most strongly associated with blue/nonblue eye color and were grouped together into a single haplotype block, the frequencies of the eight possible haplotype combinations present in the twin population were deduced using the program MENDEL (table 4). One major haplotype TGT (haplotype 1 in table 4) was predicted, representing 78.4% of alleles, with four minor haplotypes as TTT (haplotype 2 in table 4) at 7.9%, CTC (haplotype 8 in table 4) at 6.4%, with TGC (haplotype 3 in table 4) and TTC (haplotype 4 in table 4) each at 3.4%. The three other haplotypes—CGT (haplotype 5 in table 4), CTT (haplotype 6 in table 4), and CGC (haplotype 7 in table 4)—were considered rare in the twin collection, all falling well below 1%. The coding-region polymorphisms were predicted to occur as 305Arg-419Arg (haplotype 9 in table 4) at 87.2% of alleles, 305Trp-419Arg (haplotype 10 in table 4) at 5%, and 305Arg-419Gln (11) at 7.7%; the 305Trp-419Gln haplotype was not found in our sample. Logistic-regression analysis demonstrated that the remaining 55 SNPs made little additional contribution to the expression of blue eye color beyond that already deduced from the intron 1 haplotypes. Therefore, only these haplotypes and the highest frequency nonsynonymous coding-region 305 and 419 alleles were considered for association analysis with other pigmentation characteristics.
The frequencies of the predicted diplotypes for the three OCA2 intron 1 SNPs sorted from those of highest to lowest in blue eye color are shown in table 5. The 1/1 diplotype was found in 62.2% of samples; of those, 62.5% had blue eyes, 28% had green eyes (combined nonbrown 90.5%), and only 9.5% had brown eyes. The 1/4 diplotype in 4.8% of samples also had a higher frequency of blue eyes (47.1%) than brown eyes (32.6%). All other diplotypes had higher frequencies of brown eye color. The 1/2 diplotype was the second-most-common genotype, at 12.8%, and had the highest frequency (38.5%) of green eyes. The third-most-common (8.9%) diplotype, 1/8, had eye-color frequencies reciprocal to those of the 1/1 diplotype, showing only 7.9% blue and 68.8% brown eyes (combined nonblue 92.1%). These data are consistent with the TGT haplotype 1 acting as a highly penetrant recessive blue-eye-color allele. The TTC haplotype 4 is also associated with blue eyes, and the remaining haplotypes were dominant green- or brown-eye-color alleles.
For hair and skin color, the 1/1 diplotype had the highest frequency (40.2%) in subjects with light brown hair and was also enriched (92.6%) for fair/pale and medium skin types (table 5). Each of the diplotypes 1/2 to 1/5 had higher frequencies in subjects with dark brown hair and medium skin types, again consistent with TGT haplotype 1 acting as a recessive modifier associated with lighter pigmentary phenotypes. Table 5 also lists the 305 and 419 coding-region polymorphism diplotypes in eye, hair, and skin types, sorted by frequency of blue eye color. The 10/11 diplotype found in only 0.9% of samples had the highest frequency of blue eye color (50%), despite the fact that the 419Gln change on haplotype 11 was strongly associated with green eye color.22 In contrast, the 10/10 diplotype (0.3% of samples) had equal frequencies of blue and brown eye color, at 42.9% each. The 11/11 diplotype (305Arg-419Gln/305Arg-419Gln [50% of samples]) had the highest frequency (66.7%) of green eye color and no blue eyes. The 9/11 diplotype showed the second highest frequency (39.3%) of green eye color. These results highlight the association of the 419Gln change on haplotype 11 with green eye color. The most common diplotype (9/9 [75.6% of samples]) had the second highest frequency (49%) of blue eyes, greater than either the blue or brown frequencies in those of the 9/11 diplotype and again consistent with the association of the 419Gln allele with green eye color. Association of Eye Color and OCA2 SNP Alleles with Freckling and Mole Count We examined the density of facial freckling in the sample collection, sorted by eye color, on the basis of a four-point scale, as shown in fig. 3A
Assessment of freckling on three body sites, on a nine-point scale, gave median freckle scores for blue-eyed subjects at 2.0 (95% CI 1.8–2.2), green-eyed subjects at 1.0 (95% CI 0.8–1.2), and brown-eyed subjects at 1.0 (95% CI 0.9–1.1), with means of 2.25, 2.06, and 1.29, respectively. A similar trend was found for mole density (fig. 3B To test for any association of freckling or mole count with specific OCA2 SNPs, multiple-regression analysis was performed. Results indicated that the rs11855019 SNP contained within the OCA2 haplotype 1 for blue eyes had the strongest association with both a high freckling score and a high mole count. Testing of this SNP in combination with all others, including rs7495174 and rs6497268, that define the OCA2 haplotype 1, did not lead to any statistically significant improvement of these associations. In comparison of the histograms in figure 3A Discussion Understanding the genetic basis of variation in human skin, hair, and eye color has been a major goal for elucidation of the correlation of pigmentation phenotype with skin-cancer risk. Genes mutated in cases of oculocutaneous albinism are likely to have polymorphic alleles responsible for pigmentary variation within the general population34,35 and for differences among major population groups.36 OCA2 is one such gene, initially identified as the human ortholog of the p locus of mice, and, when mutated, as underlying oculocutaneous albinism type II.7,8 Deletion of the region encompassing the OCA2 gene on chromosome 15 has been associated with the hypopigmentation of the skin, hair, and eyes found in Prader-Willi and Angelman syndromes7,37,38 and with extra copies of this chromosomal region, which results in generalized hyperpigmentation of the skin.39,40 The distribution of OCA2 alleles has also been shown to affect normal pigmentation variation in admixed African American and African Caribbean populations.41 Moreover, this region has recently been reported to encompass the third-longest haplotype span of diminished heterozygosity in the genome of modern Europeans,42 which implies intense selection at this locus in ancestral European populations. An assessment of the level of polymorphism of the OCA2 coding region in several populations was first conducted by Lee et al.,12 who reported 28 nonpathogenic sequence variants, some with disparate frequencies among white, African American and African, Asian, and Indo-Pakistani populations. Later studies6,23,24,32 that included SNPs reported in GenBank identified 11 nonsynonymous amino acid substitutions within OCA2, with a further two (Val380Met and Val519Ala) newly discovered in our southeast Queensland twin collection, bringing the total to 13 (table 2). Only two of these, Arg305Trp at 0.05 and Arg419Gln at 0.09, were found to be present at any significant frequency in the 3,839 samples genotyped in this study, so OCA2 coding-region alleles account for little variation in pigmentation phenotype, at least within white populations. Moreover, similar frequencies of these nonsynonymous SNPs in other ethnic groups12 (table 6) indicate that they are not population specific. This is in contrast to the significant number of nonsynonymous variant alleles of MC1R that have been associated with red hair and fair skin in European populations.22,34,43,44
The distribution of melanin with the melanocytes of the uveal tract of the eye is the physical basis of eye color,45–48 and brown irides have up to 70% higher concentrations than do those of other colors.49,50 Age-related changes in eye color do occur, but eye color becomes stable by age 6 years.51 The genetics of human eye color has been studied for over a century,52 and, for most of that time, it was considered a simple Mendelian recessive trait, with brown eye color dominant over blue. More recently, eye color has been accepted as being a polygenic trait, with multiple genes contributing to the expressivity of eye color.18,35 However, estimates that one or more loci within the linkage region on chromosome 15 that contains the OCA2 gene explain up to 74% of the QTL variance in eye color16 confirm that there is a predominant genetic basis for eye-color variation. Here, we have shown that three SNPs within intron 1 of the gene have the highest statistical association with blue eye color (fig. 1 The most striking statistical finding of this study is that the OCA2 1/1 homozygote diplotype is at a frequency of 65% in those with blue eyes and of only 9.5% in those with brown eyes (table 5). In our previous modeling studies of the twin sample with the D15S165 marker close to the OCA2 locus, we estimated the frequencies of a dominant brown eye B allele as 21% and of a recessive b allele as 79%,22 which was close to the 26% B and 74% b allele modeled for the U.S. white population.55 The similarity of the predicted b allele and the observed OCA2 TGT haplotype 1 frequencies and the recessive action of this allele in combination with all other haplotypes (apart from TTC haplotype 4 [table 5], all other haplotypes acting like B) in the expressivity of blue eye color indicates that the intron 1 OCA2 haplotypes are diagnostic for the dominant brown eye versus the recessive blue eye trait. The recessive action of the TGT haplotype is likely to explain effects of loss or gain of alleles at this locus on the pigmentation changes associated with Prader-Willi and Angelman syndromes7,37,38 noted earlier. Nevertheless, the modeling of eye-color inheritance by use of a single locus determining eye color is insufficient to explain the range of eye color phenotypes, and the description of other loci influencing the appearance of green eye color (GEY/EYCL1 [MIM 227240]) has been noted.56 Elsewhere, we reported an interaction between eye color (by inferring OCA2 genotypes as dominant brown B and recessive b alleles) and variant MC1R alleles responsible for red hair color (RHC) by examining statistical associations of a range of pigmentary traits in a collection of white adolescent twins and family members.22,43 A modifying effect of OCA2 genotype on highly penetrant RHC alleles (indicated as “R”) was seen for constitutive skin color, freckling, and mole count. Most notable was that those carrying recessive blue eye color b/b and R/R genotypes had a significant reduction in nevus counts. Numerous studies have shown light eye color to be associated with a higher risk of melanoma,57 but this is confounded with other host pigmentary factors such as freckling58 and is also modified by MC1R genotype.22 The association of 10 OCA2 intragenic SNPs with pigmentary traits and susceptibility to melanoma in a French population has recently been reported.15 The combination of two SNPs—IVS13+112 and Ala776Ala (rs1800419)—formed a stronger association with melanoma risk than did any of the independent SNPs tested alone. Of these two SNPs, only the synonymous Ala776Ala change was tested in our twin sample, and it was found to be highly significantly associated with eye color (P=6.9×10-4). In combination with SNP IVS13+112, the Ala776Ala major T allele associated with blue eye color and the minor nonblue C allele (table 3) were reported to be highest in melanoma cases and controls, respectively. However, this combination persisted after stratification for eye color, and the biological relevance of these associations is not immediately apparent. An epidemiological examination of the contribution of the OCA2 haplotype 1 identified in this study to melanoma risk must now be considered a priority. The position of the three major diagnostic SNPs for eye color located at the 5′ end of the OCA2 gene near proximal regulatory regions immediately suggests that transcriptional regulation may be important in the action of the TGT haplotype 1. It is not apparent that the three SNPs in themselves play a direct role in expression of the OCA2 transcript levels, since scanning of the intron 1 sequence with RepeatMasker shows that the rs6497268 and rs11855019 SNPs are within interspersed repeats, and, although the rs7495174 SNP is within a unique sequence region, it does not appear to be in any transcription-factor binding site seen with the MatInspector program.59 Thus, although unlikely to be responsible for regulation of the OCA2 gene in themselves, they may be in tight linkage with regulatory elements that are affected by other changes. Another human locus that has been tested for association with pigmentary traits is the agouti signaling protein gene (ASIP).18 A g8818A/G SNP in the 3′ UTR of this gene has been reported to be associated with brown eye color60 and dark hair61 and is thought to destabilize the ASIP mRNA, which leads to premature degradation of the transcript. Quantification of the ASIP transcripts in melanocytes genotyped for this SNP did show decreases in levels of the ASIP mRNA,61 which suggests that expression of human pigmentary genes at the level of transcription occurs in genes other than OCA2. Similar analysis of OCA2 transcripts in primary melanocyte strains of defined OCA2 haplotype 1 remain to be determined. Polymorphism of gene-regulatory regions is likely to be one of the major contributors to phenotypic variation between and within human populations.62 Our data demonstrate that variation in the OCA2 gene 5′ region explains most human eye-color variation, but the molecular basis of the association with the blue/brown eye color phenotype remains to be elucidated. Acknowledgments This work was supported by National Health and Medical Research Council of Australia (NHMRC) grants 301173, 241944, and 389875 and National Cancer Institute grant CA88363. The Institute for Molecular Bioscience incorporates the Centre for Functional and Applied Genomics as a Special Research Centre of the Australian Research Council. D.L.D., G.W.M., and R.A.S. are NHMRC Senior Research Fellows. We thank Ann Eldridge and Marlene Grace, for data collection; Anjali Henders and Megan Campbell, for managing sample processing and preparation; and the twins and their families, for participation in the research. Web Resources Accession numbers and URLs for data presented herein are as follows: Albinism Database, http://albinismdb.med.umn.edu/ Entrez Nucleotide, http://www.ncbi.nlm.nih.gov/entrez/ (for human homologue of the mouse pink-eyed dilution gene [accession number NM_000275]). International HapMap Project, http://www.hapmap.org/ NCBI, http://www.ncbi.nlm.nih.gov/ (for Val380Met [ss66538500], Val519Ala [ss66538502], IVS5-53 [ss66538498], IVS18+45 [ss66538504], IVS5-39 [ss66538499], IVS13-15 [ss66538501], IVS15+78 [ss66538503], and IVS21+18 [ss66538505]). Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for MC1R, BEY2/EYCL3, HCL3, and GEY/EYCL1). SNP500Cancer, http://snp500cancer.nci.nih.gov/ References 1. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8–18 [PubMed] doi: 10.1016/S1011-1344(01)00198-1. 2. Rees JL (2004) The genetics of sun sensitivity in humans. Am J Hum Genet 75:739–751 [PubMed] 3. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ (2005) MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 571:133–152 [PubMed] 4. Sturm RA (2002) Skin colour and skin cancer—MC1R, the genetic link. Melanoma Res 12:405–416 [PubMed] doi: 10.1097/00008390-200209000-00001. 5. Brilliant MH (2001) The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res 14:86–93 [PubMed] doi: 10.1034/j.1600-0749.2001.140203.x. 6. Ramsay M, Colman MA, Stevens G, Zwane E, Kromberg J, Farrall M, Jenkins T (1992) The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet 51:879–884 [PubMed] 7. Gardner JM, Nakatsu Y, Gondo Y, Lee S, Lyon MF, King RA, Brilliant MH (1992) The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 257:1121–1124 [PubMed] doi: 10.1126/science.257.5073.1121. 8. Rinchik EM, Bultman SJ, Horsthemke B, Lee ST, Strunk KM, Spritz RA, Avidano KM, Jong MT, Nicholls RD (1993) A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 361:72–76 [PubMed] doi: 10.1038/361072a0. 9. Akey JM, Wang H, Xiong M, Wu H, Liu W, Shriver MD, Jin L (2001) Interaction between the melanocortin-1 receptor and P genes contributes to inter-individual variation in skin pigmentation phenotypes in a Tibetan population. Hum Genet 108:516–520 [PubMed] doi: 10.1007/s004390100524. 10. Suzuki I, Kato T, Motokawa T, Tomita Y, Nakamura E, Katagiri T (2002) Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 118:73–78 [PubMed] doi: 10.1046/j.1523-1747.2002.01647.x. 11. Ancans J, Flanagan N, Hoogduijn MJ, Thody AJ (2003) P-locus is a target for the melanogenic effects of MC-1R signaling: a possible control point for facultative pigmentation. Ann NY Acad Sci 994:373–377 [PubMed] 12. Lee ST, Nicholls RD, Jong MT, Fukai K, Spritz RA (1995) Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 26:354–363 [PubMed] doi: 10.1016/0888-7543(95)80220-G. 13. Eiberg H, Mohr J (1996) Assignment of genes coding for brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome 15q. Eur J Hum Genet 4:237–241 [PubMed] 14. Rebbeck TR, Kanetsky PA, Walker AH, Holmes R, Halpern AC, Schuchter LM, Elder DE, Guerry D (2002) P gene as an inherited biomarker of human eye color. Cancer Epidemiol Biomarkers Prev 11:782–784 [PubMed] 15. Jannot AS, Meziani R, Bertrand G, Gerard B, Descamps V, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, et al (2005) Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. Eur J Hum Genet 13:913–920 [PubMed] doi: 10.1038/sj.ejhg.5201415. 16. Zhu G, Evans DM, Duffy DL, Montgomery GW, Medland SE, Gillespie NA, Ewen KR, Jewell M, Liew YW, Hayward NK, et al (2004) A genome scan for eye color in 502 twin families: most variation is due to a QTL on chromosome 15q. Twin Res 7:197–210 [PubMed] doi: 10.1375/136905204323016186. 17. Posthuma D, Visscher PM, Willemsen G, Zhu G, Martin NG, Slagboom PE, de Geus EJ, Boomsma DI (2006) Replicated linkage for eye color on 15q using comparative ratings of sibling pairs. Behav Genet 36:12–17 [PubMed] doi: 10.1007/s10519-005-9007-x. 18. Frudakis T, Thomas M, Gaskin Z, Venkateswarlu K, Chandra KS, Ginjupalli S, Gunturi S, Natrajan S, Ponnuswamy VK, Ponnuswamy KN (2003) Sequences associated with human iris pigmentation. Genetics 165:2071–2083 [PubMed] 19. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–320 [PubMed] doi: 10.1038/nature04226. 20. McGregor B, Pfitzner J, Zhu G, Grace M, Eldridge A, Pearson J, Mayne C, Aitken JF, Green AC, Martin NG (1999) Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins. Genet Epidemiol 16:40–53 [PubMed] doi: 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.0.CO;2-1. 21. Zhu G, Duffy DL, Eldridge A, Grace M, Mayne C, O'Gorman L, Aitken JF, Neale MC, Hayward NK, Green AC, et al (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65:483–492 [PubMed] 22. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA (2004) Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13:447–461 [PubMed] doi: 10.1093/hmg/ddh043. 23. Oetting WS, Gardner JM, Fryer JP, Ching A, Durham-Pierre D, King RA, Brilliant MH (1998) Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no 205. Online. Hum Mutat 12:434 [PubMed] doi: 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU15>3.0.CO;2-A. 24. Kerr R, Stevens G, Manga P, Salm S, John P, Haw T, Ramsay M (2000) Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa. Hum Mutat 15:166–172 [PubMed] doi: 10.1002/(SICI)1098-1004(200002)15:2<166::AID-HUMU5>3.0.CO;2-Z. 25. Zhao ZZ, Nyholt DR, Le L, Martin NG, James MR, Treloar SA, Montgomery GW (2006) KRAS variation and risk of endometriosis. Mol Hum Reprod 11:671–676 [PubMed] doi: 10.1093/molehr/gal078. 26. Hothorn T, Hornik K, Zeileis A (2004) Unbiased recursive partitioning: a conditional inference framework. Research Report Series. Department of Statistics and Mathematics, Wirtschaftsuniversität Wien. 27. Lange K, Cantor R, Horvath S, Perola M, Sabatti C, Sinsheimer J, Sobel E (2001) MENDEL version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet Suppl 69:A1886. 28. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265 [PubMed] doi: 10.1093/bioinformatics/bth457. 29. Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176–186 [PubMed] 30. Dellavalle RP, Johnson KR, Hester EJ, Deas AM, Mokrohisky S, Morelli JG, Crane LA (2005) Children with red hair have more freckles but fewer melanocytic nevi: results from a cohort study of 280 three-year-olds. Arch Dermatol 141:1042–1043 [PubMed] doi: 10.1001/archderm.141.8.1042. 31. Sviderskaya EV, Bennett DC, Ho L, Bailin T, Lee ST, Spritz RA (1997) Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J Invest Dermatol 108:30–34 [PubMed] doi: 10.1111/1523-1747.ep12285621. 32. Suzuki T, Miyamura Y, Tomita Y (2003) High frequency of the Ala481Thr mutation of the P gene in the Japanese population. Am J Med Genet A 118:402–403 [PubMed] doi: 10.1002/ajmg.a.20044. 33. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229 [PubMed] doi: 10.1126/science.1069424. 34. Rees JL (2003) Genetics of hair and skin color. Annu Rev Genet 37:67–90 [PubMed] doi: 10.1146/annurev.genet.37.110801.143233. 35. Sturm RA, Frudakis TN (2004) Eye colour: portals into pigmentation genes and ancestry. Trends Genet 20:327–332 [PubMed] doi: 10.1016/j.tig.2004.06.010. 36. Sturm RA (2006) A golden age of human pigmentation genetics. Trends Genet 22:464–468 [PubMed] doi: 10.1016/j.tig.2006.06.010. 37. Lee ST, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA (1994) Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med 330:529–534 [PubMed] doi: 10.1056/NEJM199402243300803. 38. Spritz RA, Bailin T, Nicholls RD, Lee ST, Park SK, Mascari MJ, Butler MG (1997) Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. Am J Med Genet 71:57–62 [PubMed] doi: 10.1002/(SICI)1096-8628(19970711)71:1<57::AID-AJMG11>3.0.CO;2-U. 39. Akahoshi K, Fukai K, Kato A, Kimiya S, Kubota T, Spritz RA (2001) Duplication of 15q11.2-q14, including the P gene, in a woman with generalized skin hyperpigmentation. Am J Med Genet 104:299–302 [PubMed] doi: 10.1002/ajmg.10095. 40. Akahoshi K, Spritz RA, Fukai K, Mitsui N, Matsushima K, Ohashi H (2004) Mosaic supernumerary inv dup(15) chromosome with four copies of the P gene in a boy with pigmentary dysplasia. Am J Med Genet A 126:290–292 [PubMed] doi: 10.1002/ajmg.a.20580. 41. Shriver MD, Parra EJ, Dios S, Bonilla C, Norton H, Jovel C, Pfaff C, Jones C, Massac A, Cameron N, et al (2003) Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 112:387–399 [PubMed] 42. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. PLoS Biol 4:e72 0446–0458 [PubMed] doi: 10.1371/journal.pbio.0040072. 43. Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG (2003) The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266–272 [PubMed] doi: 10.1034/j.1600-0749.2003.00041.x. 44. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C (2005) Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 18:393–410 [PubMed] 45. Albert DM, Green WR, Zimbric ML, Lo C, Gangnon RE, Hope KL, Gleiser J (2003) Iris melanocyte numbers in Asian, African American, and Caucasian irides. Trans Am Ophthalmol Soc 101:217–222 [PubMed] 46. Imesch PD, Bindley CD, Khademian Z, Ladd B, Gangnon R, Albert DM, Wallow IH (1996) Melanocytes and iris color: electron microscopic findings. Arch Ophthalmol 114:443–447 [PubMed] 47. Imesch PD, Wallow IH, Albert DM (1997) The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Surv Ophthalmol (Suppl 2) 41:S117–S123 [PubMed] 48. Wilkerson CL, Syed NA, Fisher MR, Robinson NL, Wallow IH, Albert DM (1996) Melanocytes and iris color: light microscopic findings. Arch Ophthalmol 114:437–442 [PubMed] 49. Prota G, Hu DN, Vincensi MR, McCormick SA, Napolitano A (1998) Characterization of melanins in human irides and cultured uveal melanocytes from eyes of different colors. Exp Eye Res 67:293–239 [PubMed] doi: 10.1006/exer.1998.0518. 50. Wielgus AR, Sarna T (2005) Melanin in human irides of different color and age of donors. Pigment Cell Res 18:454–464 [PubMed] 51. Bito LZ, Matheny A, Cruickshanks KJ, Nondahl DM, Carino OB (1997) Eye color changes past early childhood: the Louisville Twin Study. Arch Ophthalmol 115:659–663 [PubMed] 52. Davenport GC, Davenport CB (1907) Heredity of eye-color in man. Science 26:589–592 doi: 10.1126/science.26.670.589-b. 53. Biswas S, Akey JM (2006) Genomic insights into positive selection. Trends Genet 22:437–446 [PubMed] doi: 10.1016/j.tig.2006.06.005. 54. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES (2006) Positive natural selection in the human lineage. Science 312:1614–1620 [PubMed] doi: 10.1126/science.1124309. 55. Hasstedt SJ (1995) Phenotypic assortative mating in segregation analysis. Genet Epidemiol 12:109–127 [PubMed] doi: 10.1002/gepi.1370120202. 56. Eiberg H, Mohr J (1987) Major genes of eye color and hair color linked to LU and SE. Clin Genet 31:186–191 [PubMed] 57. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, et al (1995) Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 62:367–376 [PubMed] 58. Tucker MA, Goldstein AM (2003) Melanoma etiology: where are we? Oncogene 22:3042–3052 [PubMed] doi: 10.1038/sj.onc.1206444. 59. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942 [PubMed] doi: 10.1093/bioinformatics/bti473. 60. Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR (2002) A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am J Hum Genet 70:770–775 [PubMed] 61. Voisey J, Gomez-Cabrera Mdel C, Smit DJ, Leonard JH, Sturm RA, van Daal A (2006) A polymorphism in the agouti signalling protein (ASIP) is associated with decreased levels of mRNA. Pigment Cell Res 19:226–231 [PubMed] doi: 10.1111/j.1600-0749.2006.00301.x. 62. Pastinen T, Hudson TJ (2004) Cis-acting regulatory variation in the human genome. Science 306:647–650 [PubMed] doi: 10.1126/science.1101659. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
J Photochem Photobiol B. 2001 Oct; 63(1-3):8-18.
[J Photochem Photobiol B. 2001]Am J Hum Genet. 2004 Nov; 75(5):739-51.
[Am J Hum Genet. 2004]Mutat Res. 2005 Apr 1; 571(1-2):133-52.
[Mutat Res. 2005]Melanoma Res. 2002 Oct; 12(5):405-16.
[Melanoma Res. 2002]Pigment Cell Res. 2001 Apr; 14(2):86-93.
[Pigment Cell Res. 2001]Am J Hum Genet. 1992 Oct; 51(4):879-84.
[Am J Hum Genet. 1992]Science. 1992 Aug 21; 257(5073):1121-4.
[Science. 1992]Nature. 1993 Jan 7; 361(6407):72-6.
[Nature. 1993]Hum Genet. 2001 Jun; 108(6):516-20.
[Hum Genet. 2001]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Eur J Hum Genet. 1996; 4(4):237-41.
[Eur J Hum Genet. 1996]Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):782-4.
[Cancer Epidemiol Biomarkers Prev. 2002]Eur J Hum Genet. 2005 Aug; 13(8):913-20.
[Eur J Hum Genet. 2005]Twin Res. 2004 Apr; 7(2):197-210.
[Twin Res. 2004]Nature. 2005 Oct 27; 437(7063):1299-320.
[Nature. 2005]Genet Epidemiol. 1999; 16(1):40-53.
[Genet Epidemiol. 1999]Am J Hum Genet. 1999 Aug; 65(2):483-92.
[Am J Hum Genet. 1999]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Am J Hum Genet. 1999 Aug; 65(2):483-92.
[Am J Hum Genet. 1999]Am J Hum Genet. 1992 Oct; 51(4):879-84.
[Am J Hum Genet. 1992]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):782-4.
[Cancer Epidemiol Biomarkers Prev. 2002]Hum Mutat. 1998; 12(6):434.
[Hum Mutat. 1998]Hum Mutat. 2000; 15(2):166-72.
[Hum Mutat. 2000]Nature. 2005 Oct 27; 437(7063):1299-320.
[Nature. 2005]Mol Hum Reprod. 2006 Nov; 12(11):671-6.
[Mol Hum Reprod. 2006]Bioinformatics. 2005 Jan 15; 21(2):263-5.
[Bioinformatics. 2005]Twin Res. 2004 Apr; 7(2):197-210.
[Twin Res. 2004]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Am J Hum Genet. 2000 Jan; 66(1):176-86.
[Am J Hum Genet. 2000]Arch Dermatol. 2005 Aug; 141(8):1042-3.
[Arch Dermatol. 2005]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Nature. 1993 Jan 7; 361(6407):72-6.
[Nature. 1993]Pigment Cell Res. 2001 Apr; 14(2):86-93.
[Pigment Cell Res. 2001]Hum Mutat. 2000; 15(2):166-72.
[Hum Mutat. 2000]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]J Invest Dermatol. 1997 Jan; 108(1):30-4.
[J Invest Dermatol. 1997]Eur J Hum Genet. 2005 Aug; 13(8):913-20.
[Eur J Hum Genet. 2005]Am J Med Genet A. 2003 May 1; 118A(4):402-3.
[Am J Med Genet A. 2003]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Science. 2002 Jun 21; 296(5576):2225-9.
[Science. 2002]Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):782-4.
[Cancer Epidemiol Biomarkers Prev. 2002]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Annu Rev Genet. 2003; 37():67-90.
[Annu Rev Genet. 2003]Trends Genet. 2004 Aug; 20(8):327-32.
[Trends Genet. 2004]Trends Genet. 2006 Sep; 22(9):464-8.
[Trends Genet. 2006]Science. 1992 Aug 21; 257(5073):1121-4.
[Science. 1992]Nature. 1993 Jan 7; 361(6407):72-6.
[Nature. 1993]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Am J Hum Genet. 1992 Oct; 51(4):879-84.
[Am J Hum Genet. 1992]Hum Mutat. 1998; 12(6):434.
[Hum Mutat. 1998]Hum Mutat. 2000; 15(2):166-72.
[Hum Mutat. 2000]Am J Med Genet A. 2003 May 1; 118A(4):402-3.
[Am J Med Genet A. 2003]Trans Am Ophthalmol Soc. 2003; 101():217-21; discussion 221-2.
[Trans Am Ophthalmol Soc. 2003]Arch Ophthalmol. 1996 Apr; 114(4):443-7.
[Arch Ophthalmol. 1996]Surv Ophthalmol. 1997 Feb; 41 Suppl 2():S117-23.
[Surv Ophthalmol. 1997]Arch Ophthalmol. 1996 Apr; 114(4):437-42.
[Arch Ophthalmol. 1996]Exp Eye Res. 1998 Sep; 67(3):293-9.
[Exp Eye Res. 1998]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Genet Epidemiol. 1995; 12(2):109-27.
[Genet Epidemiol. 1995]Science. 1992 Aug 21; 257(5073):1121-4.
[Science. 1992]N Engl J Med. 1994 Feb 24; 330(8):529-34.
[N Engl J Med. 1994]Am J Med Genet. 1997 Jul 11; 71(1):57-62.
[Am J Med Genet. 1997]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Pigment Cell Res. 2003 Jun; 16(3):266-72.
[Pigment Cell Res. 2003]Int J Cancer. 1995 Aug 9; 62(4):367-76.
[Int J Cancer. 1995]Oncogene. 2003 May 19; 22(20):3042-52.
[Oncogene. 2003]Hum Mol Genet. 2004 Feb 15; 13(4):447-61.
[Hum Mol Genet. 2004]Eur J Hum Genet. 2005 Aug; 13(8):913-20.
[Eur J Hum Genet. 2005]Bioinformatics. 2005 Jul 1; 21(13):2933-42.
[Bioinformatics. 2005]Genetics. 2003 Dec; 165(4):2071-83.
[Genetics. 2003]Am J Hum Genet. 2002 Mar; 70(3):770-5.
[Am J Hum Genet. 2002]Pigment Cell Res. 2006 Jun; 19(3):226-31.
[Pigment Cell Res. 2006]Science. 2004 Oct 22; 306(5696):647-50.
[Science. 2004]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]Hum Mutat. 1998; 12(6):434.
[Hum Mutat. 1998]Genomics. 1995 Mar 20; 26(2):354-63.
[Genomics. 1995]